The patient is a 39-year-old man who presents with pelvic lymphadenopathy. He has a history of ureteral reflux disease, recurrent nephrolithiasis, right nephrectomy, ileal loop diversion of the left ureter, and radical cystectomy for “bladder cancer,” which he underwent 3 years ago. The lymphadenopathy was discovered incidentally during recent imaging.
Dr. Thomas Flaig: This patient has a complex medical and surgical history that is remarkable for several urologic problems and procedures. As a young child, he had severe ureteral reflux disease, and 30 years ago, he underwent a right nephrectomy to remove a nonfunctioning kidney that was damaged by the reflux. At the same time, he had an ileal loop diversion on the left side, presumably to prevent similar damage to the left kidney. The patient also has a history of recurrent nephrolithiasis requiring extracorporeal shock-wave lithotripsy on multiple occasions.
Three years ago, as part of a workup for hematuria, cystoscopic evaluation revealed a bladder mass. The patient reports that he was diagnosed with “bladder cancer” and had a radical cystectomy. He is now seen in our center for evaluation of nephrolithiasis and was found to have lymphadenopathy in the pelvis.
His past medical history is notable for multiple sclerosis. A review of his family history is significant for multiple sclerosis in his mother, but no history of cancer in any first-degree relatives. His social history reveals ongoing tobacco use.
Dr. Flaig: On physical exam, the patient’s temperature is 96.6°F, pulse rate is 66/min, respiratory rate is 16/min, and his blood pressure is 132/72 mm Hg. He is in no acute distress. His lungs are clear to auscultation bilaterally. The cardiac exam reveals a regular rhythm without murmur. His abdomen is soft and nontender. Surgical scars are present and consistent with previous operative procedures. An ostomy site is present on the left side of the abdomen. His extremities are without any sign of infection or gross inflammation.
Dr. Flaig: Laboratory findings include the following: sodium, 140 mMol/L; creatinine, 1.0 mg/dL; ALT, 26 U/L; total bilirubin, 0.5 mg/dL; albumin, 4.2 g/dL; white blood cell count, 10.9 × 109/L; hemoglobin, 16.3 g/dL; and platelets, 266 × 109/L.
Dr. Flaig: Dr. La Rosa, would you please review the patient’s pathologic findings?
Dr. Francisco La Rosa: We reviewed for second opinion diagnosis the outside surgical pathology case established for this patient, consisting of a urinary bladder biopsy and a cystectomy specimen from 3 years ago. Histologic examination of the cystectomy specimen showed extensive proliferation of glands in the lamina propria (Figure 1), which were lined by columnar epithelium, including goblet cells and Paneth cells (Figure 2). Some sections showed pools of mucinous material with extravasation into the stroma (Figure 3).
Even though the diagnosis in the outside pathology report for the biopsy specimen was of an “adenocarcinoma,” we found no evidence of significant nuclear atypia, mitotic activity, necrosis, or signet ring cells. In addition, no evidence of stromal reaction or significant chronic inflammation was present around the glands and the mucinous pools. The muscularis propria had no evidence of invasion. Also submitted for our review were three right iliac lymph nodes taken at the time of the cystectomy, which showed no evidence of malignancy.
Tumors of the urinary bladder are mostly (> 90%) derived from the urothelium (transitional cell mucosa) and are usually composed of papillary formations with different grades of malignant differentiation and potential for invasion. Some of these tumors may present with areas of squamous and/or glandular differentiation. In contrast, cystitis cystica and cystitis glandularis are rare benign metaplastic changes of the urinary bladder characterized by an increased growth of the normal glandular elements within the bladder mucosa (Brunn glands). These are primarily reactive changes usually associated with chronic inflammatory processes, and should not be considered premalignant lesions. The histologic features are nests of von Brunn glands with cystic changes, which define cystitis cystica, and mucin-filled goblet cell metaplasia, which defines cystitis glandularis. In our discussion case, we observed these changes, both in the biopsy and in the cystectomy specimens.
Cystitis glandularis is found mostly in the trigone. The cystic dilatation of the glands is followed by progressive flattening of the glandular epithelium, giving origin to the morphologic changes known as cystitis cystica. Cystitis glandularis may be seen with microscopic changes in small aggregates of mucosal glands, but it may also occur as grossly identifiable polypoid masses suggesting a neoplastic process.
The histopathologic findings of cystitis glandularis and cystica should not present a diagnostic problem. The issue arises when we need to differentiate between these benign lesions and adenocarcinoma.[2,3] Cystitis glandularis and cystica are characterized by only minimal nuclear atypia without the observation of any stromal reaction, as is seen in invasive adenocarcinoma. The glands in cystitis glandularis and cystica show a well defined outline, whereas the glands in cases of adenocarcinoma are irregular and show an infiltrative behavior. Thus, invasiveness, irregular glandular contours, desmoplastic stromal reaction, and nuclear atypia are the main features that define an adenocarcinoma. Extravasation of mucinous material into the stroma may be seen in the intestinal type of cystitis glandularis—as an isolated finding, it may be difficult to differentiate from a malignant process.[4,5]
1. Eble JN, Young RH: Carcinoma of the urinary bladder: A review of its diverse morphology. Semin Diagn Pathol 14:98-108, 1997.
2. Lin JI, Yong HS, Tseng CH, et al: Diffuse cystitis glandularis. Associated with adenocarcinomatous change. Urology 15:411-415, 1980.
3. Young RH, Bostwick DG: Florid cystitis glandularis of intestinal type with mucin extravasation: A mimic of adenocarcinoma. Am J Surg Pathol 20:1462-1468, 1996.
4. Wells M, Anderson K: Mucin histochemistry of cystitis glandularis and primary adenocarcinoma of the urinary bladder. Arch Pathol Lab Med 109:59-61, 1985.
5. Newbould M, McWilliam LJ: A study of vesical adenocarcinoma, intestinal metaplasia and related lesions using mucin histochemistry. Histopathology 17:225-230, 1990.
6. Kundra V, Silverman PM: Imaging in oncology from the University of Texas
M. D. Anderson Cancer Center. Imaging in the diagnosis, staging, and follow-up of cancer of the urinary bladder. AJR Am J Roentgenol 180:1045-1054, 2003.
7. Hughes MJ, Fisher C, Sohaib SA: Imaging features of primary nonurachal adenocarcinoma of the bladder. AJR Am J Roentgenol 183:1397-1401, 2004.
8. Wong-You-Cheong JJ, Woodward PJ, Manning MA, et al: From the archives of the AFIP: Inflammatory and nonneoplastic bladder masses: Radiologic-pathologic correlation. Radiographics 26:1847-1868, 2006.
9. Gordon NS, Sinclair RA, Snow RM: Pelvic lipomatosis with cystitis cystica, cystitis glandularis and adenocarcinoma of the bladder: First reported case. Aust N Z J Surg 60:229-232, 1990.
10. Jacobs LB, Brooks JD, Epstein JI: Differentiation of colonic metaplasia from adenocarcinoma of urinary bladder. Hum Pathol 28:1152-1157, 1997.
11. Nesbit RM: Is cystitis cystica an innocent or a malefic lesion? J Urol 75:443-447, 1956.
12. Bullock PS, Thoni DE, Murphy WM: The significance of colonic mucosa (intestinal metaplasia) involving the urinary tract. Cancer 59:2086-2090, 1987.
13. Davies G, Castro JE: Cystitis glandularis. Urology 10:128-129, 1977.
14. Hochberg DA, Motta J, Brodherson MS: Cystitis glandularis. Urology 51:112-113, 1998.